These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4905152

  • 21. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.
    Capizzi RL, Bertino JR, Skeel RT, Creasey WA, Zanes R, Olayon C, Peterson RG, Handschumacher RE.
    Ann Intern Med; 1971 Jun; 74(6):893-901. PubMed ID: 5281051
    [No Abstract] [Full Text] [Related]

  • 22. [Asparaginase].
    Boiron M, Jacquillat C, Weil M, Tanzer J, Bernard J.
    Presse Med (1893); 1968 Nov 16; 76(44):2099-101. PubMed ID: 4882819
    [No Abstract] [Full Text] [Related]

  • 23. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
    Keating GM.
    BioDrugs; 2013 Aug 16; 27(4):413-8. PubMed ID: 23794007
    [Abstract] [Full Text] [Related]

  • 24. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
    Siu Chong ED, Chang TM.
    Enzyme; 1974 Aug 16; 18(3):218-39. PubMed ID: 4601662
    [No Abstract] [Full Text] [Related]

  • 25. [Preliminary studies on the treatment of acute lymphocytic leukemia of the child with L-asparaginase].
    Astaldi G, Burgio GR, Severi F, Genova R, Curtoni E, Bruschelli M, Astaldi AA.
    Haematol Lat; 1968 Aug 16; 11(4):311-47. PubMed ID: 4899936
    [No Abstract] [Full Text] [Related]

  • 26. [Antineoplastic effect of L-asparaginase].
    Opolski A.
    Postepy Hig Med Dosw; 1981 Aug 16; 35(2):177-87. PubMed ID: 7038650
    [No Abstract] [Full Text] [Related]

  • 27. L-asparaginase treatment of acute myeloblastic leukemia.
    Hansen HH, Canellos GP.
    Oncology; 1970 Aug 16; 24(5):349-57. PubMed ID: 5275037
    [No Abstract] [Full Text] [Related]

  • 28. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB.
    Lancet Oncol; 2015 Dec 16; 16(16):1677-90. PubMed ID: 26549586
    [Abstract] [Full Text] [Related]

  • 29. [L-asparaginase: A new principle in the chemotherapy of malignant neoplasms].
    Oettgen HF.
    Blut; 1969 Sep 16; 19(6):351-6. PubMed ID: 4896647
    [No Abstract] [Full Text] [Related]

  • 30. [Experimenting with the use of L-asparaginase in the treatment of neoplasms of the blood system].
    Lorie IuI, Kruglova GV, Poddubnaia IV, Mansurov AN.
    Klin Med (Mosk); 1973 Jun 16; 51(6):52-8. PubMed ID: 4774561
    [No Abstract] [Full Text] [Related]

  • 31. [Inhibition of malignant human neoplasms with L-asparaginase].
    Oettgen HF, Schulten HK.
    Klin Wochenschr; 1969 Jan 15; 47(2):65-71. PubMed ID: 4904782
    [No Abstract] [Full Text] [Related]

  • 32. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
    Adamson RH, Fabro S.
    Cancer Chemother Rep; 1968 Oct 15; 52(6):617-26. PubMed ID: 4895425
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical pharmacology of polyethylene glycol-L-asparaginase.
    Ho DH, Brown NS, Yen A, Holmes R, Keating M, Abuchowski A, Newman RA, Krakoff IH.
    Drug Metab Dispos; 1986 Oct 15; 14(3):349-52. PubMed ID: 2872037
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Psychiatric symptoms associated with L-asparaginase administration.
    Holland J, Fasanello S, Onuma T.
    J Psychiatr Res; 1974 May 15; 10(2):105-13. PubMed ID: 4531491
    [No Abstract] [Full Text] [Related]

  • 37. Clinical experience with L-asparaginase.
    Carbone PP, Haskell CM, Leventhal BG, Block JB, Selawry OS.
    Recent Results Cancer Res; 1970 May 15; 33():236-43. PubMed ID: 4949163
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME, Ertel I, Hammond GD.
    Cancer Treat Rep; 1981 May 15; 65 Suppl 4():101-7. PubMed ID: 7049373
    [Abstract] [Full Text] [Related]

  • 40. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R, Dolowy WC.
    Cancer Res; 1971 May 15; 31(5):523-6. PubMed ID: 4932205
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.